Thoracic Webinar 1: Pulmonary Surgical Oncology Task Force

The management of resectable non-small cell lung cancer (NSCLC) has entered a transformative era with the integration of immunotherapy into the neoadjuvant setting. Combining immunotherapy with chemotherapy prior to surgery has shown promising results, with multiple landmark trials—including CheckMate-816, KEYNOTE-671, AEGEAN, and Neotorch—demonstrating improved pathological response rates and survival outcomes. These findings are rapidly shaping international guidelines and redefining standards of care.

22 Jan 2026
Online

Event Information

Date/Duration

22 January 2026
18:00 – 20:00 CET Central European Time (2 Hours)
Course Director

M Casiraghi, Milan
Pulmonary Surgical Oncology Task Force Chair
Course Format

Virtual meeting
Interactive lectures and videos
Target Audience

Skills Level 1, 2 & 3 – This webinar is aimed at all Skills Levels
Course Fee

Members: Free
Non-Members: €45

EACTS Academy terms and conditions.

Course registration

This webinar will explore the biological rationale for this treatment approach, the practical considerations for patient selection, and the critical role of multidisciplinary collaboration in delivering optimal care. Participants will gain insights into staging strategies, biomarker-driven decisions, and coordination across oncology, thoracic surgery, pulmonology, and radiology.

In addition, the faculty will address real-world challenges such as managing treatment-related toxicities, optimising surgical timing, and assessing pathological responses, while also highlighting future directions for clinical research.

Designed for participants at all levels of training and experience, the session will equip attendees with a clear understanding of how to translate emerging trial data into surgical practice and patient-centred outcomes.

Course Programme

Full programme to follow shortly.

Programme and faculty subject to change